Knockdown of Livin inhibits growth and invasion of gastric cancer cells through blockade of the MAPK pathway in vitro and in vivo

Ou,J.-M.; Ye,B.; Qiu,M.-K.; Dai,Y.-X.; Dong,Q.; Shen,J.; Dong,P.; Wang,X.-F.; Liu,Y.-B.; Quan,Z.-W.; Fei,Z.-W.

doi:10.3892/ijo.2013.2171

Knockdown of Livin inhibits growth and invasion of gastric cancer cells through blockade of the MAPK pathway in vitro and in vivo

Authors:
- J.-M. Ou
- B. Ye
- M.-K. Qiu
- Y.-X. Dai
- Q. Dong
- J. Shen
- P. Dong
- X.-F. Wang
- Y.-B. Liu
- Z.-W. Quan
- Z.-W. Fei
View Affiliations

Affiliations: Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China, Department of Orthopedics, Shanghai No. 1 Rehabilitation Hospital, Shanghai 200090, P.R. China, Department of General Surgery, Xinhua Hospital (Chong Ming) Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 202150, P.R. China
Published online on: November 12, 2013 https://doi.org/10.3892/ijo.2013.2171
Pages: 276-284

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Livin, a novel member of the human inhibitors of apoptosis protein family, has been shown to be critical for tumor progression and poor prognosis for several types of malignancies. However, limited reports exist regarding the biological functions of Livin in human gastric cancer (GC). The present study investigated the clinical significance of Livin and caspase-3 (CAS-3) in human GC using immunohistochemistry assay, and explore the potential using RNA interference to knockdown Livin expression, including the subsequent effects on tumor growth and invasion in GC cells in vitro and in vivo. Our results showed that the rate of positive expression of Livin was significantly higher in GC tissues compared to that in adjacent non-cancer tissues (ANCT) (64.1 vs. 30.8%, P<0.001), while CAS-3 was lower in GC tissues than in ANCT (33.3 vs. 66.7%, P=0.001). Livin expression was positively correlated with tumor differentiation and lymph node metastases (P=0.009; P=0.007), while CAS-3 was negatively correlated with them (P=0.036; P=0.002) in patients with GC. Furthermore, knockdown of Livin inhibited cell proliferative activities and invasive potential, and induced cell in situ apoptosis in GC cells, accompanied with decreased expression of p38 MAPK, VEGF and MMP-2 and increased expression of CAS-3. In addition, the tumor volumes in the SGC7901 subcutaneous nude mouse model treated with Lv-shLivin was significantly smaller compared to those of the PBS group (P<0.01). Taken together, our findings indicate that the expression of Livin is increased in human GC and correlates with tumor differentiation and lymph node metastases, while knockdown of Livin inhibits cell growth and invasion through blockade of the MAPK pathway in GC cells, suggesting that Livin may be a potential therapeutic target for the treatment of GC.

View Figures

View References

1.	Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2.	Tajima Y, Yamazaki K, Makino R, et al: Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res. 12:6469–6479. 2006. View Article : Google Scholar
3.	Hartman ML and Czyz M: Anti-apoptotic proteins on guard of melanoma cell survival. Cancer Lett. 331:24–34. 2013. View Article : Google Scholar : PubMed/NCBI
4.	Kim DK, Alvarado CS, Abramowsky CR, et al: Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome. Pediatr Dev Pathol. 8:621–629. 2005. View Article : Google Scholar : PubMed/NCBI
5.	Kleinberg L, Lie AK, Flørenes VA, et al: Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma. Hum Pathol. 38:986–994. 2007. View Article : Google Scholar : PubMed/NCBI
6.	Nedelcu T, Kubista B, Koller A, et al: Livin and Bcl-2 expression in high-grade osteosarcoma. J Cancer Res Clin Oncol. 134:237–244. 2008. View Article : Google Scholar : PubMed/NCBI
7.	Lazar I, Perlman R, Lotem M, et al: The clinical effect of the inhibitor of apopotosis protein livin in melanoma. Oncology. 82:197–204. 2012. View Article : Google Scholar : PubMed/NCBI
8.	Liu HB, Kong CZ, Zeng Y, et al: Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment. Urol Oncol. 27:277–283. 2009. View Article : Google Scholar : PubMed/NCBI
9.	Liu H, Wang S, Sun H, et al: Inhibition of tumorigenesis and invasion of hepatocellular carcinoma by siRNA-mediated silencing of the livin gene. Mol Med Rep. 3:903–907. 2010.PubMed/NCBI
10.	Crnković-Mertens I, Bulkescher J, Mensger C, et al: Isolation of peptides blocking the function of anti-apoptotic Livin protein. Cell Mol Life Sci. 67:1895–1905. 2010.PubMed/NCBI
11.	Wang X, Xu J, Ju S, et al: Livin gene plays a role in drug resistance of colon cancer cells. Clin Biochem. 43:655–660. 2010. View Article : Google Scholar : PubMed/NCBI
12.	Dasgupta A, Alvarado CS, Xu Z, et al: Expression and functional role of inhibitor-of-apoptosis protein livin (BIRC7) in neuroblastoma. Biochem Biophys Res Commun. 400:53–59. 2010. View Article : Google Scholar : PubMed/NCBI
13.	Ding ZY, Liu GH, Olsson B, et al: Upregulation of the anti-apoptotic factor Livin contributes to cisplatin resistance in colon cancer cells. Tumour Biol. 234:683–693. 2013. View Article : Google Scholar
14.	Sun JG, Liao RX, Zhang SX, et al: Role of inhibitor of apoptosis protein Livin in radiation resistance in nonsmall cell lung cancer. Cancer Biother Radiopharm. 26:585–592. 2011. View Article : Google Scholar : PubMed/NCBI
15.	Abd-Elrahman I, Hershko K, Neuman T, et al: The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual role in tumorigenicity. Cancer Res. 69:5475–5480. 2009. View Article : Google Scholar : PubMed/NCBI
16.	Kempkensteffen C, Hinz S, Christoph F, et al: Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcome. Tumour Biol. 28:132–138. 2007. View Article : Google Scholar : PubMed/NCBI
17.	Dai CH, Li J, Shi SB, et al: Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery. Jpn J Clin Oncol. 40:327–335. 2010. View Article : Google Scholar : PubMed/NCBI
18.	Yan B: Research progress on Livin protein: an inhibitor of apoptosis. Mol Cell Biochem. 357:39–45. 2011. View Article : Google Scholar : PubMed/NCBI
19.	Xi RC, Biao WS and Gang ZZ: Significant elevation of survivin and livin expression in human colorectal cancer: inverse correlation between expression and overall survival. Onkologie. 34:428–432. 2011. View Article : Google Scholar
20.	Li J, Chen P, Li XQ, et al: Elevated levels of survivin and livin mRNA in bronchial aspirates as markers to support the diagnosis of lung cancer. Int J Cancer. 132:1098–1104. 2013. View Article : Google Scholar : PubMed/NCBI
21.	Xi RC, Sheng YR, Chen WH, et al: Expression of survivin and livin predicts early recurrence in non-muscle invasive bladder cancer. J Surg Oncol. 107:550–554. 2012.PubMed/NCBI
22.	Chang H and Schimmer AD: Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy. Mol Cancer Ther. 6:24–30. 2007. View Article : Google Scholar : PubMed/NCBI
23.	Li H, Chen Y, Chen G, et al: Expression of livin in lung cancer tissue and its relationship with the expression of caspase-3. Zhongguo Fei Ai Za Zhi. 10:486–490. 2007.PubMed/NCBI
24.	Wang TS, Ding QQ, Guo RH, et al: Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene. Biomed Pharmacother. 64:333–338. 2010. View Article : Google Scholar : PubMed/NCBI
25.	Liang YZ, Fang TY, Xu HG, et al: Expression of CD44v6 and Livin in gastric cancer tissue. Chin Med J. 125:3161–3165. 2012.PubMed/NCBI
26.	Ye L, Song X, Li S, et al: Livin-α promotes cell proliferation by regulating G1-S cell cycle transition in prostate cancer. Prostate. 71:42–51. 2011.
27.	Chen F, Yang D, Che X, et al: Livin mediates tumor cell invasion in the DU-145 cell line via NF-κB. Oncol Rep. 27:2010–2016. 2012.PubMed/NCBI
28.	Wang H, Tan SS, Wang XY, et al: Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells. Acta Pharmacol Sin. 28:1968–1974. 2007. View Article : Google Scholar : PubMed/NCBI
29.	Yang D, Song X, Zhang J, et al: Suppression of livin gene expression by siRNA leads to growth inhibition and apoptosis induction in human bladder cancer T24 cells. Biosci Biotechnol Biochem. 74:1039–1044. 2010. View Article : Google Scholar : PubMed/NCBI
30.	Yuan B, Ran B, Wang S, et al: siRNA directed against Livin inhibits tumor growth and induces apoptosis in human glioma cells. J Neurooncol. 107:81–87. 2012. View Article : Google Scholar : PubMed/NCBI
31.	Kajdaniuk D, Marek B, Fołtyn W, et al: Vascular endothelial growth factor (VEGF) in endocrinology and oncology. Endokrynol Pol. 62:14–22. 2011.PubMed/NCBI
32.	Li X, Fan S, Li L, et al: RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells. Int J Oncol. 43:159–168. 2013.PubMed/NCBI
33.	Liu C, Wu X, Luo C, et al: Antisense oligonucleotide targeting Livin induces apoptosis of human bladder cancer cell via a mechanism involving caspase 3. Exp Clin Cancer Res. 29:632010. View Article : Google Scholar : PubMed/NCBI
34.	Shin I, Kim S, Song H, et al: H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. Biol Chem. 280:14675–14683. 2005. View Article : Google Scholar : PubMed/NCBI
35.	Hideshima T, Akiyama M, Hayashi T, et al: Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu. Blood. 101:703–705. 2003. View Article : Google Scholar : PubMed/NCBI
36.	Noguchi K, Yamana H, Kitanaka C, et al: Differential role of the JNK and p38 MAPK pathway in c-Myc- and s-Myc-mediated apoptosis. Biochem Biophys Res Commun. 267:221–227. 2000. View Article : Google Scholar : PubMed/NCBI